<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26919467</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>e0150283</StartPage><MedlinePgn>e0150283</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0150283</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0150283</ELocationID><Abstract><AbstractText>The genetic association of HLA-DRB1 with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) is well documented, but association with other HLA-DR beta genes (HLA-DRB3, HLA-DRB4 and HLA-DRB5) has not been thoroughly studied, despite their similar functions and chromosomal positions. We examined variants in all functional HLA-DR beta genes in RA and SLE patients and controls, down to the amino-acid level, to better understand disease association with the HLA-DR locus. To this end, we improved an existing HLA reference panel to impute variants in all protein-coding HLA-DR beta genes. Using the reference panel, HLA variants were inferred from high-density SNP data of 9,271 RA-control subjects and 5,342 SLE-control subjects. Disease association tests were performed by logistic regression and log-likelihood ratio tests. After imputation using the newly constructed HLA reference panel and statistical analysis, we observed that HLA-DRB1 variants better accounted for the association between MHC and susceptibility to RA and SLE than did the other three HLA-DRB variants. Moreover, there were no secondary effects in HLA-DRB3, HLA-DRB4, or HLA-DRB5 in RA or SLE. Of all the HLA-DR beta chain paralogs, those encoded by HLA-DRB1 solely or dominantly influence susceptibility to RA and SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwangwoo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>So-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Dae Hyun</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo-Kyung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Chan-Bum</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Yoon-Kyoung</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Hwan</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jun</LastName><ForeName>Jae-Bum</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Young Mo</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Chang-Hee</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Seung-Cheol</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Daejeon Rheumatoid &amp; Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shin-Seok</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jisoo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Won Tae</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Dong-A University, Busan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seong-Kyu</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Arthritis &amp; Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Jung-Yoon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Arthritis &amp; Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Swapan K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hye-Soon</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR060366</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MD007909</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AR060366</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01MD007909</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059826">HLA-DRB3 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059845">HLA-DRB4 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059847">HLA-DRB5 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005802" MajorTopicYN="Y">Genes, MHC Class II</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059826" MajorTopicYN="N">HLA-DRB3 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059845" MajorTopicYN="N">HLA-DRB4 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059847" MajorTopicYN="N">HLA-DRB5 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26919467</ArticleId><ArticleId IdType="pmc">PMC4769216</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0150283</ArticleId><ArticleId IdType="pii">PONE-D-15-54816</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reche PA, Reinherz EL. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003;331: 623&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">12899833</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44: 291&#x2013;296. 10.1038/ng.1076</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.1076</ArticleId><ArticleId IdType="pmc">PMC3288335</ArticleId><ArticleId IdType="pubmed">22286218</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Kim K, Han B, Pillai NE, Ong RT, Saw WY, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 2014;23: 6916&#x2013;6926. 10.1093/hmg/ddu387</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu387</ArticleId><ArticleId IdType="pmc">PMC4245039</ArticleId><ArticleId IdType="pubmed">25070946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang SY, Lee HS, Okada Y, Han B, Saw WY, et al. The HLA-DRbeta1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun 2014;5: 5902 10.1038/ncomms6902</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6902</ArticleId><ArticleId IdType="pubmed">25533202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang SY, Lee HS, Bae SC. Construction and application of a Korean reference panel for imputing classical alleles and amino acids of human leukocyte antigen genes. PLoS One 2014;9: e112546 10.1371/journal.pone.0112546</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112546</ArticleId><ArticleId IdType="pmc">PMC4232350</ArticleId><ArticleId IdType="pubmed">25398076</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2013;41: D1222&#x2013;1227. 10.1093/nar/gks949</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks949</ArticleId><ArticleId IdType="pmc">PMC3531221</ArticleId><ArticleId IdType="pubmed">23080122</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning BL, Browning SR. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009;84: 210&#x2013;223. 10.1016/j.ajhg.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2668004</ArticleId><ArticleId IdType="pubmed">19200528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013;8: e64683 10.1371/journal.pone.0064683</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064683</ArticleId><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang SY, Lee HS, Cho SK, Choi CB, Sung YK, et al. High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann Rheum Dis 2015;74: e13 10.1136/annrheumdis-2013-204749</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204749</ArticleId><ArticleId IdType="pmc">PMC4467986</ArticleId><ArticleId IdType="pubmed">24532676</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson G. Evolution of the human HLA-DR region. Front Biosci 1998;3: d739&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">9675159</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson G, Andersson L, Larhammar D, Rask L, Sigurdardottir S. Simplifying genetic locus assignment of HLA-DRB genes. Immunol Today 1994;15: 58&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8155263</ArticleId></ArticleIdList></Reference><Reference><Citation>Satta Y, Mayer WE, Klein J. HLA-DRB intron 1 sequences: implications for the evolution of HLA-DRB genes and haplotypes. Hum Immunol 1996;51: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8911992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohjoh H, Ohashi J, Takasu M, Nishioka T, Ishida T, Tokunaga K. Recent divergence of the HLA-DRB1*04 allelic lineage from the DRB1*0701 lineage after the separation of the human and chimpanzee species. Immunogenetics 2003;54: 856&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">12671736</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotner T, Charbonneau H, Mellins E, Pious D. mRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DR beta 1 and -DR beta 3 molecules. J Biol Chem 1989;264: 11107&#x2013;11111.</Citation><ArticleIdList><ArticleId IdType="pubmed">2786876</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerwony G, Alten R, Gromnica-Ihle E, Hagemann D, Reuter U, Sorensen H, et al. Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals. Hum Immunol 1999;60: 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9952022</ArticleId></ArticleIdList></Reference><Reference><Citation>Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, et al. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol 2005;167: 108&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">16111772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>